Will Journavx, a New, Non-Addictive Painkiller, Eliminate Opioid Addiction?
The FDA has approved suzetrigine, a non-opiate signal blocker, for treatment of moderate and severe acute pain.
Exercise + Community = Recovery
A new book by Scott Strode demonstrates how the combination of exercise and community is a recipe for recovery.
An Inside Look at Addiction Treatment in Jail
A PublicSource investigation leads Allegheny County Jail in Pittsburgh, PA, to open its books on addiction treatment.
Evaluations of the Therapeutic Community in Addiction Treatment
Therapeutic communities or “wellness farms” are in the news. We take a look at their track record.
Understanding GLP-1 Discontinuation Rates
Half of the people who take GLP-1 drugs such as Ozempic quit within the first year. Why?
A Clockwork Ozempic?
A dialogue between Chris Hayes and Nicholas Reville on using GLP1-RA drugs to treat addiction.